Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.

Source:http://linkedlifedata.com/resource/pubmed/id/15273729

Oncogene 2004 Sep 2 23 40 6769-78

Download in:

View as

General Info

PMID
15273729